Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Richard W. Bond is active.

Publication


Featured researches published by Richard W. Bond.


Journal of Pharmacology and Experimental Therapeutics | 2007

A novel, orally active CXCR1/2 receptor antagonist, sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation

Richard W. Chapman; Michael Minnicozzi; Chander Celly; Jonathan E. Phillips; Ted T. Kung; R. William Hipkin; Xuedong Fan; Diane Rindgen; Gregory Deno; Richard W. Bond; Waldemar Gonsiorek; M. Motasim Billah; Jay S. Fine; John A. Hey

Sch527123 [2-hydroxy-N,N-dimethyl-3-[[2-[[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]ben-zamide] is a potent, selective antagonist of the human CXCR1 and CXCR2 receptors (Gonsiorek et al., 2007). Here we describe its pharmacologic properties at rodent CXCR2 and at the CXCR1 and CXCR2 receptors in the cynomolgus monkey, as well as its in vivo activity in models demonstrating prominent pulmonary neutrophilia, goblet cell hyperplasia, and mucus production. Sch527123 bound with high affinity to the CXCR2 receptors of mouse (Kd = 0.20 nM), rat (Kd = 0.20 nM), and cynomolgus monkey (Kd = 0.08 nM) and was a potent antagonist of CXCR2-mediated chemotaxis (IC50 ∼3–6 nM). In contrast, Sch527123 bound to cynomolgus CXCR1 with lesser affinity (Kd = 41 nM) and weakly inhibited cynomolgus CXCR1-mediated chemotaxis (IC50 ∼1000 nM). Oral treatment with Sch527123 blocked pulmonary neutrophilia (ED50 = 1.2 mg/kg) and goblet cell hyperplasia (32–38% inhibition at 1–3 mg/kg) in mice following the intranasal lipopolysaccharide (LPS) administration. In rats, Sch527123 suppressed the pulmonary neutrophilia (ED50 = 1.8 mg/kg) and increase in bronchoalveolar lavage (BAL) mucin content (ED50 =<0.1 mg/kg) induced by intratracheal (i.t.) LPS. Sch527123 also suppressed the pulmonary neutrophilia (ED50 = 1.3 mg/kg), goblet cell hyperplasia (ED50 = 0.7 mg/kg), and increase in BAL mucin content (ED50 = <1 mg/kg) in rats after i.t. administration of vanadium pentoxide. In cynomolgus monkeys, Sch527123 reduced the pulmonary neutrophilia induced by repeat bronchoscopy and lavage (ED50 = 0.3 mg/kg). Therefore, Sch527123 may offer benefit for the treatment of inflammatory lung disorders in which pulmonary neutrophilia and mucus hypersecretion are important components of the underlying disease pathology.


Tetrahedron Letters | 2000

A novel microbial metabolite, activator of low density lipoprotein receptor promoter

Vinod R. Hegde; Mohindar S. Puar; Ping Dai; Mahesh Patel; Vincent P. Gullo; Pradip R. Das; Richard W. Bond; Andrew T. McPhail

The organic extract of the fermentation broth of a Micromonospora microorganism was found to contain SCH 351448 (1), the monosodium salt of a macrocyclic dilactone containing two identical diacids. The structure and relative stereochemistry were established by single-crystal X-ray analysis. SCH 351448 is a novel ionophoric compound and is a weak activator of low density lipoprotein receptor (LDL-R) promoter with an IC50 of 25 μM.


Bioorganic & Medicinal Chemistry Letters | 2008

Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.

Younong Yu; Michael P. Dwyer; Jianping Chao; Cynthia J. Aki; Jianhua Chao; Biju Purakkattle; Diane Rindgen; Richard W. Bond; Rosemary Mayer-Ezel; James Jakway; Hongchen Qiu; R. William Hipkin; James Fossetta; Waldemar Gonsiorek; Hong Bian; Xuedong Fan; Carol Terminelli; Jay S. Fine; Daniel Lundell; J. Robert Merritt; Zhenmin He; Gaifa Lai; Minglang Wu; Arthur G. Taveras

Comprehensive SAR studies were undertaken in the 3,4-diaminocyclobut-3-ene-1,2-dione class of CXCR2/CXCR1 receptor antagonists to explore the role of the heterocycle on chemokine receptor binding affinities, functional activity, as well as oral exposure in rat. The nature of the heterocycle as well as the requisite substitution pattern around the heterocycle was shown to have a dramatic effect on the overall biological profile of this class of compounds. The furyl class, particularly the 4-halo adducts, was found to possess superior binding affinities for both the CXCR2 and CXCR1 receptors, functional activity, as well as oral exposure in rat versus other heterocyclic derivatives.


BMC Genomics | 2002

A reference database for tumor-related genes co-expressed with interleukin-8 using genome-scale in silico analysis

Lawrence Benbow; Lynn Wang; Maureen Laverty; Suxing Liu; Ping Qiu; Richard W. Bond; Eric L. Gustafson; Joseph A. Hedrick; Mitchell Kostich; Jonathan Greene; Luquan Wang

BackgroundThe EST database provides a rich resource for gene discovery and in silico expression analysis. We report a novel computational approach to identify co-expressed genes using EST database, and its application to IL-8.ResultsIL-8 is represented in 53 dbEST cDNA libraries. We calculated the frequency of occurrence of all the genes represented in these cDNA libraries, and ranked the candidates based on a Z-score. Additional analysis suggests that most IL-8 related genes are differentially expressed between non-tumor and tumor tissues. To focus on IL-8s function in tumor tissues, we further analyzed and ranked the genes in 16 IL-8 related tumor libraries.ConclusionsThis method generated a reference database for genes co-expressed with IL-8 and could facilitate further characterization of functional association among genes.


Journal of Biological Chemistry | 1997

Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I

Fang L. Zhang; Paul Kirschmeier; Donna Carr; Linda James; Richard W. Bond; Lynn Wang; Robert Patton; William T. Windsor; Rosalinda Syto; Rumin Zhang; W. Robert Bishop


Biochemistry | 1998

Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue.

Corey Strickland; William T. Windsor; Rosalinda Syto; Lynn Wang; Richard W. Bond; Zhen Wu; Jeffrey Schwartz; Hung V. Le; Lorena S. Beese; Patricia C. Weber


Journal of Biological Chemistry | 1995

Novel Tricyclic Inhibitors of Farnesyl Protein Transferase BIOCHEMICAL CHARACTERIZATION AND INHIBITION OF Ras MODIFICATION IN TRANSFECTED Cos CELLS

Bishop Wr; Richard W. Bond; Joanne M. Petrin; Lynn Wang; Robert Patton; Ronald J. Doll; Njoroge G; Joseph J. Catino; Schwartz J; William T. Windsor


Archive | 2003

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

Arthur G. Taveras; Cynthia J. Aki; Richard W. Bond; Jianping Chao; Michael P. Dwyer; Johan A. Ferreira; Jianhua Chao; Younong Yu; John J. Baldwin; Bernd Kaiser; Ge Li; J. Robert Merritt; Purakkattle J. Biju; Kingsley H. Nelson; Laura Rokosz; James Jakway; Gaifa Lai; Minglang Wu; Evan A. Hecker; Daniel Lundell; Jay S. Fine


Journal of Medicinal Chemistry | 2006

Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Michael P. Dwyer; Younong Yu; Jianping Chao; Cynthia J. Aki; Jianhua Chao; Purakkattle J. Biju; Viyyoor M. Girijavallabhan; Diane Rindgen; Richard W. Bond; Rosemary Mayer-Ezel; James Jakway; R. William Hipkin; James Fossetta; Waldemar Gonsiorek; Hong Bian; Xuedong Fan; Carol Terminelli; Jay S. Fine; Daniel Lundell; J. Robert Merritt; Laura L. Rokosz; Bernd Kaiser; Ge Li; Wei Wang; Tara M. Stauffer; Lynne Ozgur; Jack E. Baldwin; Arthur G. Taveras


Journal of Biological Chemistry | 1994

Phosphorylation of Thr642 is an early event in the processing of newly synthesized protein kinase C beta 1 and is essential for its activation.

Ji Zhang; Lynn Wang; J. Schwartz; Richard W. Bond; W. R. Bishop

Collaboration


Dive into the Richard W. Bond's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge